Pricing Log in Create free account

Jade Biosciences, Inc. (JBIO) vs Oric Pharmaceuticals, Inc. (ORIC)

Jade Biosciences, Inc. and Oric Pharmaceuticals, Inc. are both Biotechnology companies. Jade Biosciences, Inc. and Oric Pharmaceuticals, Inc. are of similar size ($896.7M and $880.0M). Across the 9 metrics below, Jade Biosciences, Inc. leads on 5 and Oric Pharmaceuticals, Inc. on 4.

Valuation

Metric JBIO ORIC Biotechnology median
P/E n/m n/m 10.60
P/S n/m n/m 9.40
P/B 2.09 2.49 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales n/m n/m 9.02
Earnings yield (15.30%) (15.34%) (32.88%)
Free cash flow yield (13.49%) (11.81%) (23.13%)

Profitability

Metric JBIO ORIC Biotechnology median
Gross margin 0.00% 0.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (46.16%) (39.80%) (51.96%)
Return on assets (42.54%) (37.35%) (46.06%)
Return on invested capital 0.00% (83.77%) 0.00%

Growth

Metric JBIO ORIC Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) 78.57% 19.67% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric JBIO ORIC Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 14.93 13.19 4.97
Net debt to EBITDA 2.94 1.95 1.01

Dividend

Metric JBIO ORIC Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric JBIO ORIC Biotechnology median
Market cap 896.72m 880.01m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack